Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 52.57 | N/A |
| PEG Ratio (TTM) | -1.46 | N/A |
| P/S Ratio (TTM) | 2.26 | N/A |
| P/B Ratio (TTM) | 3.15 | N/A |
| P/FCF Ratio (TTM) | 16.13 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.42 | N/A |
| Price to 5YR AVG FCF Ratio | 7.57 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.09% | N/A |
| ROE (TTM) | 6.46% | N/A |
| Net Profit Margin (TTM) | 4.28% | N/A |
| ROIC 5YR AVG | 20.21% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 134.79% | 41.75% | 23.50% |
| Revenue | 4.25% | 35.79% | 32.18% |
| Net Income | 163.25% | 39.88% | 26.83% |
| Cash Flow | 156.53% | 22.50% | 142.56% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.58 | N/A |
| Quick Ratio (TTM) | 1.58 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 3.48 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.71 | N/A |
| LTL to 5YR AVG FCF | 5.97 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.89% | N/A |